Objective: The relationship between insomnia symptoms and cognitive performance is unclear, particularly at the population level. We conducted the largest examination of this association to date through analysis of the UK Biobank, a large populationbased sample of adults aged 40-69 yrs. We also sought to determine associations between cognitive performance and self-reported chronotype, sleep medication use, and sleep duration.
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Introduction
Insomnia disorder is defined as persistent difficulties with sleep initiation and/or maintenance, resulting in significant impairment to daytime functioning. At the symptom level, insomnia affects up to one-third of the adult population, while persistent insomnia disorder affects approximately 10-12% and is associated with increased risk for cardiovascular disease, depression and early mortality. 1, 2 Both daytime functioning and quality of life are known to be severely affected in those with insomnia and often drive treatment-seeking. [3] [4] [5] More specifically, previous work
shows that the most commonly cited areas of daytime dysfunction are problems with fatigue, work performance, cognitive performance and emotion regulation 6 . Insomnia has also been associated with a range of serious and non-serious sleep-related accidents 7 .
While experimental sleep loss engenders reliable cognitive impairment, particularly for vigilance, complex attention and working memory, 8 there has been comparatively little work on insomnia. In general, the field has been characterised by mixed findings, with some studies showing impairment and others failing to observe differences from controls. 9 Nevertheless, meta-analytic data suggest that patients exhibit reliable impairments in tasks probing episodic memory, working memory and problem solving, with small-to-medium effect sizes. 10 Recent, well-controlled studies find evidence of insomnia-related impairments in switching of attention and working memory, 11 and sustained attention and episodic memory. 12 However, there continues to be conflicting findings in the insomnia literature [13] [14] [15] and studies generally recruit small samples of patients with "primary insomnia", who are otherwise healthy.
Larger epidemiology-based studies of insomnia symptoms and cognitive performance similarly display mixed results: showing evidence of impairment, 16 no evidence of impairment, 17 or impairment only for specific insomnia sub-groups. 15, 18 M A N U S C R I P T
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To our knowledge, no study has investigated insomnia symptoms and cognitive performance in a large population-based sample of middle-aged adults, with a standardised test battery, while simultaneously appraising the influence of other important sleep variables, including chronotype, sleep duration, and sleep medication.
The aim of the present study was to conduct the largest investigation of insomnia symptoms and cognitive performance to date, through analysis of UK biobank data.
The UK biobank is a large population-based study of >500,000 adults aged between 40 and 69, providing a unique opportunity to assess associations in groups of poor and good sleepers, and to adequately control for the influence of several potential confounding variables. We hypothesised that insomnia would be independently associated with impairments in all measures of cognition (reasoning, basic reaction time, numeric memory, visual memory and prospective memory) after controlling for potential confounding variables. As a secondary aim we examined associations between cognitive performance and chronotype, sleep medication use, and selfreported sleep duration.
Methods
Participants
Details of the UK Biobank are available elsewhere. 19 In brief, adults aged 40 to 69 years who were registered with the UK National Health Service and living within 25 miles of a study assessment centre were invited to participate. Approximately 9 million invitations led to a final sample of 501,718 participants. For the purposes of the present study, participants were excluded if they self-reported a neurological condition (e.g., neurodegenerative disease, stroke, head injury, epilepsy; n=22,065), had a diagnosis of sleep-disordered breathing (n=1,511), or had incomplete data for insomnia symptoms (n=613), leaving a total of 477,529. Twenty-eight percent of the M A N U S C R I P T A C C E P T E D 
Sleep-related variables
To assess insomnia symptoms, participants were asked "Do you have trouble falling asleep at night or do you wake up in the middle of the night?" with responses "never/rarely", "sometimes", and "usually". Participants were categorised as having frequent insomnia symptoms if they answered "usually" to this question, while the remaining participants made up the control group without frequent insomnia symptoms. Chronotype was assessed using the following question, "Do you consider yourself to be"…: "definitely a 'morning' person", "more a 'morning' than 'evening' person", "more an 'evening' than 'morning' person", "definitely an 'evening' person". relationships with health and cognition, 20 we categorised sleep duration into short (<7 hrs), normal (7-9 hrs) and long (>9hrs) based on recent guidelines. 21 Finally, as a manipulation check to support group categorisation (insomnia symptoms vs. no insomnia symptoms), subjective daytime impairment was coded based on answers to the following question: "Over the past two weeks, how often have you felt tired or had little energy?", with the following response options: "not at all", "several days", "more than half the days", or "nearly every day".
Cognitive Performance
Five cognitive measures were administered via computerised touchscreen interface. 22 Time to complete all five cognitive tests was approximately 15 minutes.
The tests were designed specifically for UK Biobank, in order to allow administration at scale without examiner supervision. The tasks show evidence of an underlying performance factor and good stability over time, with the exception of verbal memory performance which has a comparatively lower intraclass correlation coefficient. 22 Briefly, the assessments included:
• reasoning: this task assessed the ability to solve thirteen verbal and numeric reasoning problems. Each problem had five possible response options. The dependent variable was total number of correct answers given (range 0-13) within a two-minute period, with higher scores indicating better performance;
• basic reaction time: this task was delivered in the style of the card game, 'snap', and requested participants to respond with a button press when they • visual memory: In this task six card-pairs of symbols were presented onscreen in a random pattern. Cards were then turned face down on the screen and participants were asked to locate as many symbol pairs as possible in as few attempts as possible. The dependent variable was the number of errors made during pairs matching (range 0-146), which was log-transformed due to skewed distribution and zero-inflation (ln (x+1));
• prospective memory: In this task participants were asked to remember to carry out a pre-planned instruction after a filled interval. At the beginning of the test battery they were presented with the following instruction: "At the end of the games we will show you four coloured symbols and ask you to touch the blue square. However, to test your memory, we want you to actually touch the orange circle instead." If participants remembered to touch the orange circle on first attempt they were coded as "correct" (1), while those failing to do so were set to 0.
Demographic data
Demographic data included age, sex and neighborhood-level socioeconomic status as measured by the Townsend index of material deprivation. For statistical analyses, socioeconomic status was log-transformed due to skewed distribution using an 'ln (x+7)' equation (minimum of non-transformed index: -6.26). Educational qualifications were recorded, and were dichotomised according to whether or not participants held
a college / university degree. We also included body mass index (BMI) as a covariate in adjusted analyses.
Medication and clinical data
Current medications were self-reported to the research nurse, and participants were dichotomised according to whether or not they were taking sleep medication (sedatives and hypnotics), any other psychotropic medication (mood stabilisers, antidepressants, antipsychotics), or antihypertensive medication (ACE inhibitors, angiotensin II antagonists, beta blockers, calcium channel blockers, diuretics).
Current depressive symptoms were assessed using the following question, "Over the past two weeks, how often have you felt down, depressed or hopeless?" with the following response options: "not at all", "several days", "more than half the days" or "nearly every day". For the purpose of the present analyses, those scoring "several days", "more than half the days", or "nearly every day" were coded in the "depressive symptoms" category, while those scoring "not at all" were considered in the "no depressive symptoms" category. In addition, participants were dichotomised according to whether or not they reported hypertension or any cardiovascular disease.
Analyses
Descriptive data presentation included mean values and standard deviations, as well as the proportion of the sample reporting specific questionnaire response options.
Questionnaire response options, 'do not know' or 'prefer not to answer', were handled as missing values. For cognitive dependent variables, sample size varied across tests because the reasoning and prospective memory tests were added after commencement of data collection, while the numeric memory task was included from the outset but subsequently removed due to time constraints. Given that we analysed five cognitive tests, the alpha level was set at p<0.01 for all analyses.
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Results
Sample description
Sociodemographic data for the sample are presented in Table 1 . Those with frequent insomnia symptoms were older and more likely to be female, reported shorter sleep duration, were more likely to report using sleep medication, were less likely to hold a university or college degree, were from a lower socioeconomic background, had a higher BMI, were more likely to report hypertension, use of antihypertensive medication or cardiovascular disease, were more likely to report recent depressive M A N U S C R I P T
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11 symptoms and were more likely to report taking psychotropic medication (all p<0.001).
[Insert Table 1 here]
Association between insomnia symptoms and cognitive performance
Results from statistical models are presented in Table 2 . In unadjusted analyses (model 1), frequent insomnia symptoms were associated with worse performance on the reasoning test, basic reaction time test, numeric memory test, and visual memory test. There was no statistically significant association between insomnia status and performance on the prospective memory test after correction for multiple testing.
[Insert Table 2 
Discussion
The principal aim of the present study was to examine cross-sectional associations between insomnia symptoms and cognitive performance in a large population-based sample. We also sought to assess relationships between cognitive performance and sleep duration, chronotype and sleep medication use. Prevalence, demographic and comorbidity profile of those with insomnia symptoms was consistent with previous M A N U S C R I P T A C C E P T E D 23 It is possible that our samples are overlapping.
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There may also be trait factors relevant to poor sleepers that aid compensation and/or performance facilitation. For example, hyperarousal across cognitive, emotional and neurophysiological levels is characteristic of insomnia 25 and has been suggested to support cognitive performance on relatively brief tasks with low cognitive load. 26 In support of this, at least two studies have observed quicker reaction times on basic vigilance tasks in insomnia patients relative to controls. 27, 28 Hyperarousal has in turn been proposed to hinder performance on more cognitively challenging tasks 29, 30 and it may be that tests used in the present study were not of sufficient sensitivity and/or complexity to unmask insomnia-related impairment. 31 Another possibility is that unmeasured personality traits known to be associated with insomnia may contribute to enhanced cognitive performance. We and others have shown that those with insomnia often display high levels of perfectionism, captured through questionnaire and behavioural measures. [32] [33] [34] [35] [36] Preliminary work suggests that high levels of perfectionism may confer advantage on specific task-dependent variables under certain conditions. 37 However, studies have also revealed that perfectionistic traits (and associated processes, like rumination) may be obstructive to task performance. 38 Thus, the drivers behind the observed statistical advantage remain speculative and unclear, but could involve both etiological and methodological factors. Of note, supplementary analysis (see supplementary Table   1 ) comparing those reporting insomnia symptoms "sometimes" with those reporting insomnia symptoms "never/rarely" did not reveal group differences in adjusted models. However, consistent with results presented above, those with frequent insomnia symptoms performed better relative to those reporting insomnia symptoms "never/rarely". There is, therefore, no clear dose-response effect between frequency of insomnia symptoms and cognitive performance. our study is particularly noteworthy given our ability to partial out the effect of M A N U S C R I P T
Chronotype, sleep medication, and sleep duration
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16 potential confounders, including both sleep and non-sleep variables. We were not able to record history or duration of sleep medication use but both acute and chronic use of benzodiazepines/benzodiazepine receptor agonists is known to be associated with cognitive and psychomotor impairment, 47 while their discontinuation in chronic users is associated with improved cognitive status. 48 Sleep medication use appears to be more robustly associated with cognitive impairment than insomnia symptoms, and functional and structural neuroimaging parameters is now required to shed light on putative brain mechanisms underlying performance profiles.
Limitations
Our study has several important caveats. First, this was a cross-sectional study and therefore our findings cannot elucidate causality. Second, our cognitive dependent variables were created for brief completion on large numbers of participants and hence have not undergone formal validation. In partial mitigation, principal components analyses support an expected underlying performance (g) factor across tasks, and test-retest suggests good stability for most task dependent variables. 22 Moreover, associations with variables in the expected direction (e.g. with age, education), evidence of impairment in those with psychiatric disorder, 23 and associations with several genetic variants 49 provide further support of task validity.
However, tasks were brief and did not parametrically manipulate cognitive load, and the battery did not sample additional domains of cognition; potentially contributing to limited sensitivity for insomnia-related impairment. Third, our sleep trait predictor variables were limited by their low-resolution, reflecting just single item self-report M A N U S C R I P T A C C E P T E D 51 Sixth, sample size differed across statistical models owing to missing data for specific covariates of interest. However, we note that when analyses are restricted to complete data across all models, findings remain unchanged (see Supplementary   Table 2 ). Finally, our analyses are based exclusively on Gaussian linear models, and we have not tested whether nonlinear and/or non-Gaussian models would reveal more nuanced associations between our predictor and outcome variables.
Conclusion
In our large UK sample frequent insomnia symptoms were not independently associated with cognitive impairment. Indeed, contrary to our hypotheses, we found a small statistical advantage for those with frequent insomnia symptoms over those without, which is unlikely to be clinically meaningful. Our data in no way undermine 2, 3, 4) group differences between three possible insomnia groupings [U = experiencing insomnia symptoms "usually" vs. "never/rarely"; S = experiencing insomnia symptoms "sometimes" vs. "never/rarely"; O = original test, experiencing insomnia symptoms "usually" vs. "sometimes"+"never/rarely"]. 
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